Salubrinal (Figure 3) is a synthetic organic compound known to inhibit the serine phosphatase protein phosphatase 1 (PP1) and eukaryotic translational initiation factor 2α (eIF2α) (65), which was used to test for inhibition against PAC1 as a potential rheumatoid arthritis treatment. Here, EIF2A is linked to rheumatoid arthritis.